Question 1: PTH increases calcium reabsorption at which site in the kidney?
A) Proximal tubule only
B) Loop of Henle
C) Distal convoluted tubule
D) Collecting duct
Explanation: Parathyroid hormone (PTH) increases calcium reabsorption primarily in the distal convoluted tubule of the nephron. It does this by stimulating calcium channels in the apical membrane and activating transporters that move calcium from the tubular lumen into the renal cells and then into the bloodstream. This effect helps maintain normal serum calcium levels.
Question 2: PTH decreases phosphate reabsorption at which site in the kidney?
A) Proximal tubule
B) Distal convoluted tubule
C) Loop of Henle
D) Collecting duct
Explanation: Parathyroid hormone (PTH) decreases phosphate reabsorption mainly in the proximal tubule of the nephron. It achieves this by downregulating sodium-phosphate co-transporters in the apical membrane of proximal tubular cells, which reduces phosphate uptake from the filtrate back into the blood. As a result, more phosphate is excreted in the urine. This action of PTH helps maintain normal serum calcium levels while preventing hyperphosphatemia.
Question 3: The active form of vitamin D is synthesized in which organ?
A) Liver
B) Kidney
C) Intestine
D) Parathyroid glands
Explanation: The kidney converts 25-hydroxyvitamin D to its active form, 1,25-dihydroxyvitamin D, under the influence of PTH.
Question 4: PTH indirectly increases intestinal calcium absorption by stimulating the production of:
A) Calcitonin
B) Aldosterone
C) 1,25-dihydroxyvitamin D
D) Cortisol
Explanation: Parathyroid hormone (PTH) indirectly increases calcium absorption in the intestines by stimulating the kidneys to convert 25-hydroxyvitamin D into its active form, 1,25-dihydroxyvitamin D (calcitriol). Calcitriol then acts on the intestinal lining to increase the synthesis of calcium-binding proteins, enhancing dietary calcium absorption. This mechanism allows PTH to raise serum calcium levels not only by acting on the kidneys and bone but also by improving intestinal calcium uptake.
Question 5: Which electrolyte abnormality is characteristic of primary hyperparathyroidism?
A) Hypercalcemia and hypophosphatemia
B) Hypocalcemia and hyperphosphatemia
C) Hypercalcemia and hyperphosphatemia
D) Hypocalcemia and hypophosphatemia
Explanation: In primary hyperparathyroidism, excess parathyroid hormone (PTH) increases calcium levels in the blood by stimulating bone resorption, enhancing calcium reabsorption in the distal convoluted tubules of the kidney, and promoting the production of active vitamin D to increase intestinal calcium absorption. At the same time, PTH decreases phosphate reabsorption in the proximal tubules, leading to hypophosphatemia. The combination of hypercalcemia and low phosphate is therefore characteristic of this condition.
Question 6: The most common cause of primary hyperparathyroidism is:
A) Parathyroid carcinoma
B) Parathyroid hyperplasia
C) Parathyroid adenoma
D) Vitamin D deficiency
Explanation: The most common cause of primary hyperparathyroidism is a single parathyroid adenoma, which is a benign tumor of one of the parathyroid glands. This adenoma autonomously secretes excess parathyroid hormone (PTH), leading to hypercalcemia and its associated symptoms. Less commonly, primary hyperparathyroidism can result from parathyroid hyperplasia or, rarely, parathyroid carcinoma.
Question 7: Which bone finding is associated with advanced hyperparathyroidism?
A) Osteoporosis
B) Osteitis fibrosa cystica
C) Rickets
D) Osteomalacia
Explanation: In advanced hyperparathyroidism, excess PTH causes increased bone resorption, leading to weakened bones. This can result in a condition called osteitis fibrosa cystica, characterized by subperiosteal bone resorption, cystic lesions, and brown tumors. These changes reflect severe, chronic overactivity of the parathyroid glands and can lead to bone pain, fractures, and skeletal deformities.
Question 8: Chvostek's sign and Trousseau's sign are clinical indicators of:
A) Hypercalcemia
B) Hypocalcemia
C) Hyperphosphatemia
D) Vitamin D toxicity
Explanation: Chvostek's sign and Trousseau's sign are classic clinical indicators of hypocalcemia. Low calcium levels increase the excitability of nerves and muscles because calcium normally helps stabilize neuronal membranes. When calcium is low, neurons fire more easily, leading to characteristic neuromuscular signs. Chvostek’s sign is tested by tapping the facial nerve just in front of the ear. In a person with hypocalcemia, this causes twitching of the facial muscles on the same side. Trousseau’s sign is elicited by inflating a blood pressure cuff on the arm above systolic pressure for several minutes. In hypocalcemia, this can provoke a spasm of the hand and forearm, known as a carpopedal spasm.
Question 9: Hypocalcemia due to parathyroid gland damage most commonly occurs after which surgical procedure?
A) Appendectomy
B) Cholecystectomy
C) Thyroidectomy
D) Parathyroidectomy
Explanation: Hypocalcemia caused by parathyroid gland damage most commonly occurs after thyroidectomy. During this surgical procedure, the parathyroid glands, which are located on or near the back of the thyroid, can be accidentally removed or injured. Since these glands produce parathyroid hormone (PTH), which regulates calcium levels, any damage can lead to a decrease in PTH and a subsequent drop in blood calcium levels. This post-surgical hypocalcemia can present with neuromuscular irritability, including tetany, muscle cramps, and the positive Chvostek or Trousseau signs. Monitoring calcium levels after thyroidectomy is therefore essential, and calcium or vitamin D supplementation may be required to prevent or treat these complications..
Question 10: Which artery must be carefully preserved to avoid ischemia to the parathyroid glands during thyroid surgery?
A) Superior thyroid artery
B) Inferior thyroid artery
C) Common carotid artery
D) External carotid artery
Explanation: The parathyroid glands receive most of their blood supply from the inferior thyroid artery, which must be preserved during thyroidectomy.
Question 11: The parathyroid glands develop embryologically from which pharyngeal pouches?
A) First and second
B) Second and third
C) Third and fourth
D) Fourth and fifth
Explanation: The parathyroid glands develop embryologically from the third and fourth pharyngeal pouches. Specifically, the inferior parathyroid glands arise from the third pharyngeal pouch along with the thymus, while the superior parathyroid glands originate from the fourth pharyngeal pouch. During development, these glands migrate to their final positions behind the thyroid gland. This migration explains why the inferior parathyroids can sometimes be found in ectopic locations, including within the thymus. Understanding their embryological origin is important, particularly in surgery, because variations in location can affect the identification and preservation of the glands during procedures such as thyroidectomy.
Question 12: The most common cause of secondary hyperparathyroidism is:
A) Chronic kidney disease
B) Vitamin D intoxication
C) Parathyroid adenoma
D) Hypercalcemia
Explanation: The most common cause of secondary hyperparathyroidism is chronic kidney disease (CKD). In CKD, the kidneys are unable to excrete phosphate efficiently, leading to hyperphosphatemia, which in turn lowers serum calcium levels. Additionally, the diseased kidneys have a reduced ability to convert vitamin D to its active form, 1,25-dihydroxyvitamin D (calcitriol). This decreases intestinal calcium absorption, further contributing to hypocalcemia. In response to low calcium levels, the parathyroid glands increase parathyroid hormone (PTH) secretion, resulting in secondary hyperparathyroidism. Over time, persistent stimulation can cause parathyroid hyperplasia and significant alterations in bone metabolism.
Question 13: The drug cinacalcet is used to treat hyperparathyroidism by:
A) Increasing PTH secretion
B) Increasing sensitivity of calcium-sensing receptors
C) Blocking calcium channels
D) Inhibiting bone resorption
Explanation: Cinacalcet is a drug used in the management of hyperparathyroidism, particularly secondary hyperparathyroidism in chronic kidney disease or in cases of parathyroid carcinoma. It works by increasing the sensitivity of calcium-sensing receptors (CaSRs) on the surface of parathyroid cells. By making these receptors more responsive to circulating calcium levels, cinacalcet tricks the parathyroid glands into sensing higher calcium than is actually present, which leads to suppressed parathyroid hormone (PTH) secretion. This reduction in PTH helps to correct the disturbances in calcium and phosphate metabolism associated with hyperparathyroidism, thereby protecting bone health and reducing complications related to high PTH levels.
Question 14: Which laboratory findings are most characteristic of primary hyperparathyroidism?
A) Low calcium, low phosphate, low PTH
B) Low calcium, high phosphate, high PTH
C) High calcium, high phosphate, low PTH
D) High calcium, low phosphate, high PTH
Explanation: In primary hyperparathyroidism, excess PTH causes high calcium levels by increasing calcium release from bone, kidney reabsorption, and gut absorption via vitamin D activation. At the same time, PTH reduces phosphate reabsorption in the kidneys, leading to low phosphate levels.
Question 15: Which condition presents with elevated PTH, hypocalcemia, and hyperphosphatemia?
A) Primary hyperparathyroidism
B) Secondary hyperparathyroidism
C) Tertiary hyperparathyroidism
D) Hypoparathyroidism
Explanation: In secondary hyperparathyroidism, chronic low calcium levels (often from chronic kidney disease) stimulate continuous PTH release. Because the kidneys can't excrete phosphate well, phosphate levels rise, while calcium stays low despite the high PTH. This results in high PTH, low calcium, and high phosphate.
Question 16: Which condition presents with low PTH, hypocalcemia, and hyperphosphatemia?
A) Hypoparathyroidism
B) Secondary hyperparathyroidism
C) Tertiary hyperparathyroidism
D) Pseudohypoparathyroidism
Explanation: In hypoparathyroidism, the parathyroid glands do not produce enough PTH. Without sufficient PTH, calcium reabsorption in the kidneys and bone release of calcium decrease, leading to low blood calcium levels (hypocalcemia). At the same time, phosphate is not excreted properly, causing high phosphate levels (hyperphosphatemia). This classic trial (low PTH, low calcium, and high phosphate) is a key feature of hypoparathyroidism.
Question 17: In tertiary hyperparathyroidism, PTH secretion becomes:
A) Excessive due to positive feedback
B) Normal despite high calcium
C) Excessive and autonomous
D) Stimulated by vitamin D
Explanation: In tertiary hyperparathyroidism, the parathyroid glands become overactive and no longer respond to normal feedback mechanisms. This usually develops after long-standing secondary hyperparathyroidism, such as in patients with chronic kidney disease, where persistent low calcium levels continuously stimulate PTH release. Over time, the parathyroid glands enlarge (hyperplasia) and start secreting PTH excessively and autonomously, even when calcium levels are normal or high. This loss of regulation leads to severe hypercalcemia and requires surgical intervention in many cases.
Question 18: A patient with neck surgery develops hoarseness and hypocalcemia. Which structure was most likely damaged?
A) Superior thyroid artery
B) Inferior thyroid artery
C) Recurrent laryngeal nerve
D) External carotid artery
Explanation: Injury to the recurrent laryngeal nerve during thyroid or parathyroid surgery causes hoarseness, while parathyroid gland damage causes hypocalcemia.
Question 19: Which imaging technique is most useful in localizing parathyroid adenomas preoperatively?
A) Ultrasound
B) Sestamibi scan
C) MRI
D) CT scan
Explanation: The sestamibi scan is the most effective imaging technique for identifying parathyroid adenomas before surgery. It uses a small amount of a radioactive tracer (technetium-99m sestamibi) that is absorbed by overactive parathyroid tissue. Parathyroid adenomas take up and retain the tracer longer than normal tissue, allowing them to be clearly visualized on the scan. This helps surgeons locate the abnormal gland precisely, which is especially important in minimally invasive parathyroidectomy. While ultrasound can also be used, it is more operator-dependent and less accurate, especially in patients with a large thyroid gland or ectopic parathyroid tissue. MRI and CT scans are generally not first-line but may be used if the adenoma cannot be located using sestamibi or ultrasound.
Question 20: Which hormone has the opposite effect of PTH on calcium levels?
A) Vitamin D
B) Calcitonin
C) Aldosterone
D) Cortisol
Explanation: Calcitonin lowers blood calcium levels, opposing the effects of PTH.
Question 21: Which receptor type mediates PTH action on target cells?
A) G protein-coupled receptor
B) Tyrosine kinase receptor
C) Ion channel receptor
D) Nuclear receptor
Explanation: PTH binds to G protein-coupled receptors on target cells to mediate its effects.
Report Card
Total Questions Attempted: 0
Correct Answers: 0
Wrong Answers: 0
Percentage: 0%

0 Comments